FLT3 and acute myeloid leukemia: Furthermore, in multivariable analysis of clinical and genetic variables in the VIALE‐A cohort, only genetic variables (TP53MUT, KRASMUT, NRASMUT, and FLT3‐ITDMUT) were significant, whereas age ≥ 75 years, male gender, secondary AML, baseline blast counts, and ECOG performance status were not [11].